1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > General Medicine and Specialty Medicine Analysis & Statistics, August 2016 (p7)

General Medicine and Specialty Medicine Analysis & Statistics, August 2016 (p7)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

181-210 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Middle East and Africa Optical Imaging Market By Type, Applications, Geography and Vendors - Forecasts, Trends and Shares (2015- 2020)

Middle East and Africa Optical Imaging Market By Type, Applications, Geography and Vendors - Forecasts, Trends and Shares (2015- 2020)

  • $ 2 200
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Africa is home to about 11% of the worlds people but it carries about 24% of the global disease burden both in human and financial costs. The private sector plays a major part in financing the healthcare ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Africa
Autism - Pipeline Review, H2 2016

Autism - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Autism - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Autism - Pipeline Review, H2 2016’, provides an overview of the Autism pipeline landscape. The report provides comprehensive information ...

  • Industries : Mental Health, General Medicine and Specialty Medicine, Pathology
Urinary Incontinence - Pipeline Review, H2 2016

Urinary Incontinence - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Urinary Incontinence - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H2 2016’, provides an overview of the Urinary Incontinence pipeline landscape. ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States, World
Cerebral Palsy - Pipeline Review, H2 2016

Cerebral Palsy - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Cerebral Palsy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cerebral Palsy - Pipeline Review, H2 2016’, provides an overview of the Cerebral Palsy pipeline landscape. The report provides ...

  • Industries : Mental Health, General Medicine and Specialty Medicine, Pathology
  • Countries : World, United States
Canavan Disease - Pipeline Review, H1 2016

Canavan Disease - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Canavan Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Canavan Disease - Pipeline Review, H1 2016’, provides an overview of the Canavan Disease pipeline landscape. The report ...

  • Industries : Mental Health, Pathology, Biological Therapy
  • Countries : United States
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H1 2016

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H1 2016’, ...

  • Industries : Mental Health, Pathology, Therapy, Pharmaceutical
  • Countries : United States
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey

  • $ 1 995
  • Industry report
  • July 2016
  • by Global Data

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and ...

  • Industries : Healthcare, Medical Device, Pharmaceutical
  • Countries : Turkey, Asia
Ablynx NV - Product Pipeline Review - 2016

Ablynx NV - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • May 2016
  • by Global Markets Direct

Ablynx NV - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Ablynx NV - Product Pipeline Review - 2016’, provides an overview of the Ablynx NV’s pharmaceutical research and development ...

  • Industries : Biopharmaceutical
  • Countries : World
Urology Care Products - Market Trends & Insights

Urology Care Products - Market Trends & Insights

  • $ 1 495
  • Industry report
  • June 2016
  • by Global Industry Analysts

This report presents Insights into the Urology Care Products Market. Illustrated with 27 data tables, the report comprises of a brief statistical summarization of worldwide market including Australia, ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Japan, North America, Europe, World, Australia, Brazil
Global Hearing Aids Market by Devices (Behind-The-Ear, In-The-Ear, Receiver-In-The-Ear, Completely-In-The-Canal, In-The-Canal), Implant Types (Cochlear Implant, Bone Anchored Systems), OTC Amplifiers, Diagnostic Instruments, Country Wise Market and Sales

Global Hearing Aids Market by Devices (Behind-The-Ear, In-The-Ear, Receiver-In-The-Ear, Completely-In-The-Canal, In-The-Canal), Implant Types (Cochlear Implant, Bone Anchored Systems), OTC Amplifiers, Diagnostic Instruments, Country Wise Market and Sales

  • $ 1 390
  • Industry report
  • July 2016
  • by Igate Research

The global hearing aids market is expected to grow at a CAGR of around 5% during the period 2016 - 2021. The growing prevalence of hearing impairment coupled with an expanding global geriatric population ...

  • Industries : Pathology
  • Countries : World
Gazyva 2015 U.S Physician Engagement Report

Gazyva 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Gilotrif 2015 U.S Physician Engagement Report

Gilotrif 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Ninlaro 2015 U.S Physician Engagement Report

Ninlaro 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Xgeva 2015 U.S Physician Engagement Report

Xgeva 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Avastin 2015 U.S Physician Engagement Report

Avastin 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, Cancer, Pathology, General Medicine and Specialty Medicine
  • Countries : United States
Lenvima 2015 U.S Physician Engagement Report

Lenvima 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Imlygic 2015 U.S Physician Engagement Report

Imlygic 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Erivedge 2015 U.S Physician Engagement Report

Erivedge 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Adcetris 2015 U.S Physician Engagement Report

Adcetris 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Herceptin 2015 U.S Physician Engagement Report

Herceptin 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Jakafi 2015 U.S Physician Engagement Report

Jakafi 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Keytruda 2015 U.S Physician Engagement Report

Keytruda 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Tagrisso 2015 U.S Physician Engagement Report

Tagrisso 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Pomalyst 2015 U.S Physician Engagement Report

Pomalyst 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Torisel 2015 U.S Physician Engagement Report

Torisel 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Yervoy 2015 U.S Physician Engagement Report

Yervoy 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Cometriq 2015 U.S Physician Engagement Report

Cometriq 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Arzerra 2015 U.S Physician Engagement Report

Arzerra 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Opdivo 2015 U.S Physician Engagement Report

Opdivo 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Erbitux 2015 U.S Physician Engagement Report

Erbitux 2015 U.S Physician Engagement Report

  • $ 1 350
  • Industry report
  • July 2016
  • by MDDetails

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains ...

  • Industries : Therapy, General Medicine and Specialty Medicine
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.